ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Statement from FDA Commissioner on Oversight of REMS Associated with Transmucosal Immediate-Release Fentanyl Products
August 03, 2018On Aug. 3, the U.S. Food and Drug Administration will be hosting a public advisory committee meeting to review data from the most recent assessment of the Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU) for transmuc
Pharma Sources Insight January 2025
